The OpenAI Foundation is officially putting its money where its mission is. Chair Bret Taylor announced the foundation will invest at least $1 billion over the next year across life sciences, jobs, AI resilience, and community programs. This is part of a previously disclosed $25 billion commitment aimed at curing diseases and building resilience against AI’s potential downsides. The first major focus is life sciences, with an emphasis on Alzheimer’s research. The foundation plans to partner with leading institutions to use AI’s data-crunching abilities to map disease pathways, detect biomarkers sooner, and personalize treatments. The foundation sees its role as two-sided: pushing AI to solve humanity’s biggest problems while also preparing society for the new challenges advanced AI will bring. Why it matters: This signals a major shift from AI companies just building models to actively funding real-world applications and safeguards, setting a precedent for how the industry’s profits get reinvested into public benefit.